These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 469255)

  • 1. Demonstration of circulating immune complexes in Sjögren's syndrome.
    Lawley TJ; Moutsopoulos HM; Katz SI; Theofilopoulos AN; Chused TM; Frank MM
    J Immunol; 1979 Sep; 123(3):1382-7. PubMed ID: 469255
    [No Abstract]   [Full Text] [Related]  

  • 2. IgA rheumatoid factor and IgA containing immune complexes in primary Sjögren's syndrome.
    Atkinson JC; Fox PC; Travis WD; Popek E; Katz RW; Balow JE; Pillemer SR
    J Rheumatol; 1989 Sep; 16(9):1205-10. PubMed ID: 2810277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Circulating immune complexes and cellular cytotoxic reactions in Sjögren's syndrome].
    Nasonov EL; Vasil'ev VI; Aleksandrova EN; Nasonova SV; Timofeeva EB
    Ter Arkh; 1988; 60(4):13-6. PubMed ID: 2969150
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of Sjögren's syndrome with C4 deficiency, defective reticuloendothelial function and circulating immune complexes.
    Hersey P; Lawrence S; Prendergast D; Bindon C; Benson W; Valk P
    Clin Exp Immunol; 1983 Jun; 52(3):551-60. PubMed ID: 6872316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and partial characterization of immune complexes in patients with rheumatoid arthritis plus Sjogren's syndrome and with Sjogren's syndrome alone.
    Yoshinoya S; McDuffy S; Alarcon-Segovia D; Pope RM
    Clin Exp Immunol; 1982 May; 48(2):339-47. PubMed ID: 6980743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical aspects of Sjögren's syndrome].
    Ofuji T
    Ryumachi; 1983 Feb; 23(1):50-8. PubMed ID: 6867870
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulmonary disorders associated with Sjögren's syndrome.
    Fairfax AJ; Haslam PL; Pavia D; Sheahan NF; Bateman JR; Agnew JE; Clarke SW; Turner-Warwick M
    Q J Med; 1981; 50(199):279-95. PubMed ID: 7330166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reticuloendothelial Fc receptor function in patients with Sjogren's syndrome.
    O'Sullivan MM; Walker DM; Williams BD
    Clin Exp Immunol; 1985 Sep; 61(3):483-8. PubMed ID: 4075586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating immune complexes in Sjögren's syndrome.
    Ichikawa Y; Takaya M; Arimori S
    Tokai J Exp Clin Med; 1980 Oct; 5(4):367-74. PubMed ID: 6166090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A syndrome of multiple immune autoreactivity. A breakdown in immune regulation.
    Diaz LA; Glamb RW; Silva J
    Arch Dermatol; 1980 Jan; 116(1):77-9. PubMed ID: 6986118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune complexes in Sjögren's syndrome.
    Fischbach M; Char D; Christensen M; Daniels T; Whaley K; Alspaugh M; Talal N
    Arthritis Rheum; 1980 Jul; 23(7):791-5. PubMed ID: 6902669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte complement C3b receptor (CR1) levels and immune complex-induced manifestations in patients with primary Sjögren's syndrome.
    Thomsen BS; Oxholm P; Nielsen H; Manthorpe R
    Scand J Rheumatol Suppl; 1986; 61():127-30. PubMed ID: 2954207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement inhibitor C4b-binding protein in primary Sjögren's syndrome and its association with other disease markers.
    Zadura AF; Theander E; Blom AM; Trouw LA
    Scand J Immunol; 2009 Apr; 69(4):374-80. PubMed ID: 19284503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection and partial characterization of circulating immune complexes with solid-phase anti-C3.
    Pereira AB; Theofilopoulos AN; Dixon FJ
    J Immunol; 1980 Aug; 125(2):763-70. PubMed ID: 6156214
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemorheologic disturbances and circulating immune complexes in patients with rheumatic diseases].
    Loskutova TT; Koreshkov GG; Nasonov EL; Zakharchenko VN; Larionov SM
    Ter Arkh; 1989; 61(5):51-5. PubMed ID: 2781490
    [No Abstract]   [Full Text] [Related]  

  • 16. Necrotizing lesions in Sjögren's syndrome. I. An immunofluorescent study.
    Friedman H; Egami M; Kilmar V
    Z Rheumatol; 1980; 39(1-2):28-32. PubMed ID: 7424196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating immune complexes (CIC) in connective tissue diseases (CTD).
    Schrieber L; Maini RN
    Neth J Med; 1984; 27(9):327-39. PubMed ID: 6239983
    [No Abstract]   [Full Text] [Related]  

  • 18. [The importance of determining circulating immune complexes in the differential diagnosis of chronic parotitis and Sjögren's syndrome].
    Jović N; Cvetinović M; Radojicić C; Knezević M
    Chir Maxillofac Plast; 1988; 18(1-3):61-5. PubMed ID: 3267503
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic and prognostic value of quantitative immunohistological examination of lip biopsy in Sjögren's syndrome.
    Bodeutsch C; de Wilde PC; Kater L; van den Hoogen FH; de Jong AJ; Borstlap WA; van de Putte LB; Vooijs GP
    Neth J Med; 1991 Apr; 38(3-4):110-6. PubMed ID: 1881496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of the treatment of Sjögren's syndrome with TFX (thymus factor X)].
    Fiedorowicz-Fabrycy I; Kordecka E; Ostanek L
    Wiad Lek; 1992 Jun; 45(11-12):409-13. PubMed ID: 1441520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.